NCT00814281View on ClinicalTrials.gov

Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

May 31, 2009

Conditions
Airway Inflammation
Interventions
OTHER

placebo

Placebo

DRUG

Montelukast

10 mg ingested orally 1 hour prior to exercise testing

Trial Locations (1)

18509

Marywood University, Scranton

All Listed Sponsors
lead

Marywood University

OTHER

NCT00814281 - Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man? | Biotech Hunter | Biotech Hunter